References
- Rao R, Honavar SG, Mulay K, Reddy VAP. Primary orbital low-grade fibromyxoid sarcoma – a case report. Indian J Ophthalmol. Apr 2019;67(4):568–570. doi:10.4103/ijo.IJO_633_18.
- Gjorgova Gjeorgjievski S, Fritchie K, Thangaiah JJ, Folpe AL, Din NU. Head and neck low-grade fibromyxoid sarcoma: a clinicopathologic study of 15 cases. Head Neck Pathol. Sep 2021;16:434–443. doi:10.1007/s12105-021-01380-y.
- Evans HL. Low-grade fibromyxoid sarcoma. A report of two metastasizing neoplasms having a deceptively benign appearance. Am J Clin Pathol. Nov 1987;88(5):615–619. doi:10.1093/ajcp/88.5.615.
- Evans HL. Low-grade fibromyxoid sarcoma. A report of 12 cases. Am J Surg Pathol. Jun 1993;17(6):595–600. doi:10.1097/00000478-199306000-00007.
- Evans HL. Low-grade fibromyxoid sarcoma: a clinicopathologic study of 33 cases with long-term follow-up. Am J Surg Pathol. Oct 2011;35(10):1450–1462. doi:10.1097/PAS.0b013e31822b3687.
- Doyle LA, Moller E, Dal Cin P, Fletcher CD, Mertens F, Hornick JL. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma. Am J Surg Pathol. May 2011;35(5):733–741. doi:10.1097/PAS.0b013e318210c268.
- Lau PP, Lui PC, Lau GT, Yau DT, Cheung ET, Chan JK. EWSR1-CREB3L1 gene fusion: a novel alternative molecular aberration of low-grade fibromyxoid sarcoma. Am J Surg Pathol. May 2013;37(5):734–738. doi:10.1097/PAS.0b013e31827560f8.
- Arbajian E, Puls F, Magnusson L, Thway K, Fisher C, Sumathi VP, et al. Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma. Am J Surg Pathol. Jun 2014;38(6):801–808. doi:10.1097/PAS.0000000000000158.
- van Houdt WJ, Westerveld CM, Vrijenhoek JE, van Gorp J, van Coevorden F, Verhoef C, et al. Prognosis of solitary fibrous tumors: a multicenter study. Ann Surg Oncol. Dec 2013;20(13):4090–4095. doi:10.1245/s10434-013-3242-9.
- Chamberlain F, Engelmann B, Al-Muderis O, Messiou C, Thway K, Miah A, et al. Low-grade fibromyxoid sarcoma: treatment outcomes and efficacy of chemotherapy. In Vivo In Vivo. Jan–Feb 2020;34(1):239–245. doi:10.21873/invivo.11766.